Profile picture

Doctor Jorge Plutzky

Brigham and Women's Hospital, Boston (United States of America)
Follow
Logo ESC

Contributor content

Semaglutide effects on incidence and reoccurrence of atrial fibrillation in the SELECT trial
Presentation
Semaglutide effects on incidence and reoccurrence of atrial fibrillation in the SELECT trial
Cardiovascular outcomes & atherosclerosis: How do GLP-1 receptor antagonist provide benefits?
Presentation
Cardiovascular outcomes & atherosclerosis: How do GLP-1 receptor antagonist provide benefits?
Understanding epigenetics - The potential rationale for BET inhibition in management of cardiovascular disease.
Presentation
Understanding epigenetics - The potential rationale for BET inhibition in management of cardiovascular disease.
Panel discussion - Improving CV outcomes in type 2 diabetes: A novel role for GLP-1 receptor agonists?
Presentation
Panel discussion - Improving CV outcomes in type 2 diabetes: A novel role for GLP-1 receptor agonists?
Cardiovascular effects of GLP-1 receptor agonists.
Presentation
Cardiovascular effects of GLP-1 receptor agonists.
Understanding BET inhibition as a novel pathway for cardiovascular risk modulation.
Presentation
Understanding BET inhibition as a novel pathway for cardiovascular risk modulation.

ESC 365 is supported by